These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20167050)

  • 1. Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic.
    Goldstein E; Miller JC; O'Hagan JJ; Lipsitch M
    Influenza Other Respir Viruses; 2010 Mar; 4(2):101-12. PubMed ID: 20167050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predispensing of antivirals to high-risk individuals in an influenza pandemic.
    Goldstein E; Miller JC; O'Hagan J; Lipsitch M
    PLoS Curr; 2009 Aug; 1():RRN1007. PubMed ID: 20029604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California.
    Hunter JC; Rodríguez DC; Aragón TJ
    BMC Public Health; 2012 Jan; 12():82. PubMed ID: 22276659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.
    Gutiérrez-Mendoza LM; Schwartz B; Méndez de Lira Jde J; Wirtz VJ
    Bull World Health Organ; 2012 Oct; 90(10):782-7. PubMed ID: 23109746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.
    Reddy D
    J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii35-ii40. PubMed ID: 20215134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of Antiviral Allocation Scheme for Pandemic Influenza Depends on Strain Transmissibility, Delivery Delay and Stockpile Size.
    Lydeamore M; Bean N; Black AJ; Ross JV
    Bull Math Biol; 2016 Feb; 78(2):293-321. PubMed ID: 26846916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.
    Greer AL; Schanzer D
    PLoS One; 2013; 8(6):e67253. PubMed ID: 23805303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.
    Borders-Hemphill V; Mosholder A
    Influenza Other Respir Viruses; 2012 Nov; 6(6):e129-33. PubMed ID: 22681766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Views on Alternative Methods for Antiviral Distribution and Dispensing During an Influenza Pandemic.
    SteelFisher GK; Benson JM; Caporello H; Koonin LM; Patel A; Ben-Porath E; Blendon RJ
    Health Secur; 2018; 16(2):108-118. PubMed ID: 29570363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating antiviral effectiveness against pandemic influenza using household data.
    Glass K; Becker NG
    J R Soc Interface; 2009 Aug; 6(37):695-703. PubMed ID: 19064345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispensing antivirals in underserved communities.
    Kondro W
    CMAJ; 2009 Oct; 181(9):E199-200. PubMed ID: 19770254
    [No Abstract]   [Full Text] [Related]  

  • 14. Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008-2010.
    Suda KJ; Regen SM; Lee TA; Easterling JL; Hunkler RJ; Danziger LH
    Int J Antimicrob Agents; 2014 Mar; 43(3):279-83. PubMed ID: 24373618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.
    O'Hagan JJ; Wong KK; Campbell AP; Patel A; Swerdlow DL; Fry AM; Koonin LM; Meltzer MI
    Clin Infect Dis; 2015 May; 60 Suppl 1(0 1):S30-41. PubMed ID: 25878299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can antiviral drugs contain pandemic influenza transmission?
    Becker NG; Wang D
    PLoS One; 2011 Mar; 6(3):e17764. PubMed ID: 21464934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy.
    Bearman GM; Shankaran S; Elam K
    Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):152-6. PubMed ID: 20334616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivirals in the 2009 pandemic--lessons and implications for future strategies.
    Berera D; Zambon M
    Influenza Other Respir Viruses; 2013 Nov; 7 Suppl 3(Suppl 3):72-9. PubMed ID: 24215385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.
    Williams LO; Kupka NJ; Schmaltz SP; Barrett S; Uyeki TM; Jernigan DB
    J Clin Virol; 2014 May; 60(1):27-33. PubMed ID: 24630481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
    Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH
    BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.